Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier
Aldo Torre,1,2 Jacqueline Córdova-Gallardo,3 Alberto C Frati Munari4 1Guest Research, Metabolic Unit Department, Instituto Nacional de Ciencias Médicas Y Nutrición "Salvador Zubirán", México City, Mexico; 2Guest Research, Liver Unit Department, Hospital General de México, México City, Mexi...
Saved in:
Main Authors: | Torre A (Author), Córdova-Gallardo J (Author), Frati Munari AC (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy
by: Wang Z, et al.
Published: (2018) -
Progressive multifocal leukoencephalopathy, more than an encephalopathy
by: David Sáez M, et al.
Published: (2022) -
Diverticular Disease and Rifaximin: An Evidence-Based Review
by: Anna Piccin, et al.
Published: (2023) -
Efficacy and Safety of Rifaximin Versus Placebo or Other Active Drugs in Critical ill Patients With Hepatic Encephalopathy
by: Xianghui Han, et al.
Published: (2021) -
RIFAXIMIN TO TREAT OF GASTROINTESTINAL INFECTIONS
by: article editorial
Published: (2008)